SecBot SecBot
SECBOTREPLAY Home › Report › VRTX

VRTX · CEO files 144 for 11,866 shares

VERTEX PHARMACEUTICALS INC / MA · 144 filed Nov 6, 2026 at 10:29 ET

At the news

NEUTRALIMPACT 2/10

144 filed Nov 6, 2026 at 10:29 ET

Vertex CEO Reshma Kewalramani filed a Form 144 notice of intent to sell 11,866 shares of common stock, with an approximate market value of $6.3 million based on the filing date. The shares were acquired through ESPP purchases and restricted stock vesting between May 2024 and August 2025. This represents a routine insider sale for diversification or tax planning, not a change in fundamental outlook.

  • CEO Reshma Kewalramani filed Form 144 on 2026-11-06 to sell 11,866 shares of VRTX common stock.
  • Estimated aggregate market value of the proposed sale is $6,307,134.98 based on the filing date price.
  • Shares were acquired through ESPP purchases (69 shares on 05/14/2024, 53 shares on 05/14/2025) and restricted stock vesting (1,744 shares on 02/24/2025, 10,000 shares on 08/06/2025).
  • The sale is planned for execution on or after 11/06/2026 on Nasdaq.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access